Hemoglobin Level, Coagulopathy Profile and Electrolyte Balance
Learn more about:
Related Clinical Trial
Safety and Efficacy of Injectable Poly-L-Lactic Acid for Volume Loss in the Temples Using Dual Plane Injections
Exploratory Study of the Relationships Between the Biomarkers of Inflammation, Lipidome and Insulin Resistance and Disorders of Glycemic Regulation in a Cohort of Insulin-resistant Subjects Due to Excess Weight or Dunnigan’s Lipodystrophy
Natural History of Pregnancy and Pregnancy Outcomes in Metreleptin-Treated vs Untreated Subjects With Lipodystrophy
Intraoperative Fluid Management of Liposuction , Cardiometry Versus Rohrich Formula
The Visceral Adiposity Measurement and Observation Study
Evaluating the Performance and Safety of the Medical Device Plenhyage® in the Treatment of Dermal Tissue Defects
Evaluating the Performance and Safety of the Medical Device Auralya® in the Treatment of Facial Dermal Tissue Defects
Evaluating the Performance and Safety of the Medical Device Janesse in the Treatment of Facial Dermal Tissue Defects
Evaluating Performance and Safety of the Medical Device Jalucomplex in the Treatment of Facial and Neck Tissue Defects
Changes in Weight, Body Composition and Cardiac Risk After Discontinuing Abacavir Treatment in HIV-infected Individuals
Changes in Weight, Body Composition and Metabolic Parameters After Discontinuing Dolutegravir or Tenofovir Disproxil
Effect of Berberine on Metabolic Syndrome, Efficacy and Safety in Combination With Antiretroviral Therapy in PLWH.
Hemoglobin Level, Coagulopathy Profile and Electrolyte Balance
Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects
Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome
Exercise and Pioglitazone for HIV-Metabolic Syndromes
Observational Study of Changes in Fat Distribution and Blood Metabolites in HIV Infected Adults
Yoga for the Management of HIV-Metabolic Syndromes
Pravastatin for Hyperlipidaemia in HIV.
A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth
Exercise for Patients With HIV Infections
Lactate Metabolism Study in HIV Infected Persons
Quality of Life, Sleep, and Biomarkers in People With HIV/AIDS
The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs
Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities
Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients
Safety Study of Antria Cell Preparation Process to Enhance Facial Fat Grafting With Adipose Derived Stem Cells
Growth Hormone Dynamics and Cardiac Steatosis in HIV
The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected Children
Immune Response to Pneumococcal Vaccination in Aging HIV Positive Adults
Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir.
Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers
Detraining in People Living With HIV/AIDS
Changing to Nonprotease Inhibitor Treatment to Improve Side Effects
Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids
Perceived Changes in Body Build and Image in Patients Who Are Now Taking or Recently Have Stopped Taking Anti-HIV Drugs
SHARE: Simple HAART With Abacavir, Reyataz, and Epivir
The Effects of Anabolic Steroids and Protease Inhibitors on People Living With HIV/AIDS
Observational Study of Fat Loss in HIV Infected Adults Taking Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Metabolism and Body Shape of Healthy Children and Children With Chronic Infections
White Light Scanning to Aid Body Contouring: A Pilot Project
Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients
The Effect of Low-Dose Human Growth Hormone Therapy in HIV Infected Patients
Study Comparing Reducing the Dose of Stavudine Versus Switching to Tenofovir in HIV-Infected Patients Receiving Antiretroviral Therapy
The Cleveland Cardiometabolic Cohort
Metabolic Abnormalities in HIV-infected Persons
Clinical Evaluation of Venus Versa Octipolar Applicator for Reduction of Abdomen Circumference
Factors Mediating Gut Microbiota Dysbiosis and Metabolic Disease in HIV Patients.
Underlying Abnormalities in Fat and Muscle Leading to Lipodystrophy Syndrome
Effects of Short-term Growth Hormone in HIV-infected Patients
Safety Study of Filler Agent Composed of Autologous Mesenchymal Stem Cells and Hyaluronic Acid
Raltegravir Therapy for Women With HIV and Fat Accumulation
The PREFORM Study: A Study to Evaluate the Safety and Efficacy of Rotational Fractional Resection on Submental Contouring
Effects of IGF-I in HIV Metabolic Disease
Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome
Effectiveness of Nucleoside Supplementation or Switch to Tenofovir in Reversing Fat Loss in HIV Infected Adults
Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy
Effects of Growth Hormone Releasing Hormone in HIV
A Study of Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive Patients
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
Body Composition and Adipose Tissue in HIV
Study to Evaluate Changes in Limb Fat When Switching From a Thymidine Analogue
CONFORM: Rotational Fractional Resection for Submental Contouring
Study of Alpha-2 Adrenergic Receptor Dysfunction in Regional Lipoatrophy
TH9507 in Patients With HIV-Associated Lipodystrophy
TH9507 Extension Study in Patients With HIV- Associated Lipodystrophy
Study Evaluating the Impact on Fat Distribution of Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimens in Antiretroviral Experienced Patients With Lipoatrophy
Clinical Trial to Assess the Effect of the Change of Efavirenz (EFV) for Lopinavir/Ritonavir (LPV/r) in Lipoatrophy in HIV-infected Patients
Energy Expenditure of People Living With HIV/AIDS
Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS)
Egrifta Replacement and Sleep Disordered Breathing
Clinical Trial to Determine the Efficacy of Sculptra™ Dermal Filler for the Correction of Contour Deformities Caused by Lipoatrophy
Low Energy Diet and Familial Partial Lipodystrophy
Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy
A Study to Determine How and Why HIV-Infected Subjects on Anti-viral Treatment Develop Lipodystrophy
Adipocyte, Insulin-resistance and Immunity : Evaluation of Interleukin-7 in Lipodystrophy, Diabetes and Obesity
Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy
Role of the Autonomic Nervous System in HIV-Lipodystrophy
Leptin for Abnormal Lipid Kinetics in HIV Lipodystrophy Syndrome
Therapeutic Approaches to HAART-Induced Lipodystrophy
Different Surgical Modalities for Thigh Lipodystrophy Including Liposuction,Thigh Lift and Liposuction Assisted Thigh Lift
Leptin to Treat Lipodystrophy
Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy
Leptin to Treat Lipodystrophy
Prevalence of Lipodystrophy Syndrome and Its Role as Cause of Metabolic Disturbances
Efficacy, Safety and Tolerability of ISIS 304801 in People With Partial Lipodystrophy With an Open-Label Extension
Shock Waves for Treatment of Gynoid Lipodystrophy and Localized Fat
Corticosteroid-induced Lipodystrophy and Adipokines
Short-term Effects of Leptin in People With Lipodystrophy
Lipodystrophy Connect Patient Registry
An Open-Label Treatment Protocol to Provide Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With Lipodystrophy
Autologous Adipose-Derived Stem Cell Transplantation in Patients With Lipodystrophy